LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

LAMP-Kit Diagnoses Non-Falciparum Malaria

By LabMedica International staff writers
Posted on 26 Jan 2017
Print article
Image: Three typical trophozoites of Plasmodium ovale in a thin blood smear; note the fimbriation and Schüffner\'s dots (Photo courtesy of the Centre for Agriculture and Bioscience International).
Image: Three typical trophozoites of Plasmodium ovale in a thin blood smear; note the fimbriation and Schüffner\'s dots (Photo courtesy of the Centre for Agriculture and Bioscience International).
Malaria incidence has recently been declining globally, although in many African countries it is still one of the top health problems and the efforts to control and eradicate malaria will still need a strong diagnostic capacity, which allows any parasitaemic patient to be detected and treated sooner.

Loop-mediated isothermal amplification (LAMP) is a simple molecular diagnostic method based on the principle of isothermal amplification, which does not require special equipment or special distribution in laboratories, and provide results in 60 minutes. A LAMP-kit can be used in the field without special equipment and could have an important role in malaria control programs in endemic areas and for malaria diagnosis in returned travelers.

Scientists at the National Center for Microbiology of Majadahonda and their colleagues have determined the diagnostic validity of a LAMP-kit to diagnose Plasmodium ovale and compare it to microscopy and conventional multiplex nested polymerase chain reaction (nPCR) in the diagnosis of P. ovale infections in archived clinical specimens. They also compared the naked eye reading of the amplification products with the automated reading by turbidimetry as well as to determine the specificity of the P. falciparum LoopAmp primer in specimens of patients infected with P. ovale.

Plasmodium ovale positive samples (29, tested by PCR and/or microscopy) and malaria negative specimens (398, tested by microscopy and PCR) were collected in different hospitals of Europe from June 2014 to March 2016. DNA was extracted from all samples and amplification was performed with LoopAMP MALARIA kit in an Eiken 500 automated turbidimeter. The results of LAMP read by turbidimetry and with the naked eye were compared.

The LAMP-kit showed a sensitivity of 100% and a specificity of 97.24% with positive and negative predictive values of 72.5% and 100%, respectively. Naked eyed readings were in accordance with turbidimetry readings (sensitivity, 92.5%, specificity, 98.96% and positive and negative predictive values, respectively, 90.24% and 99.22%). The limit of detection of LAMP assay for P. ovale was between 0.8 and 2 parasites/µL. P. falciparum LAMP reactions were found to be negative in 29 out of 29 confirmed P. ovale samples. The one P. ovale sample positive by P. falciparum LAMP was excluded as it was found to be also positive for P. falciparum by nPCR.

The authors concluded that the Pan primer of the Malaria kit LoopAMP can detect P. ovale at very low-levels and it showed a predictive negative value of 100%. The relative simplicity of the LAMP procedure and the low infrastructure costs open a range of opportunities by bringing molecular-level parasite detection and capacity of using malaria LAMP in field settings. The study was published on January 7, 2017, in the Malaria Journal.

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Automatic Nucleic Acid Extractor
GeneRotex 24

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
LGC Clinical Diagnostics